BenchSci vs Causaly
BenchSciDrug Discovery Platforms
CustomPublished price
CausalyDrug Discovery Platforms
CustomPublished price
BenchSci Drug Discovery Platforms AI for antibody research. | Causaly Drug Discovery Platforms Unlock R&D decision velocity with the Agentic AI platform for life sciences | |
|---|---|---|
| Overview | ||
| Category | Drug Discovery Platforms | Drug Discovery Platforms |
| What it is | BenchSci provides an AI platform that helps scientists find published antibody data to improve experiment design and reduce reagent waste. | AI-powered biomedical research platform extracting causal relationships from scientific literature for pharma. |
| Pricing | ||
| Published price | Custom BenchSci's ASCEND platform is enterprise-only, quoted per organization by user count and depth of internal data integration (ELN/LIMS); no public rate card. Limited free access is… | Custom Enterprise life-sciences AI platform sold via sales contact; no public pricing. Priced per organization/seat and scope; customers include 12 of the top 20 pharma companies. |
| Pricing model | Custom quote | Custom quote |
| Free options | Free plan · Free trial | No free plan · No free trial |
| Deal on Cubbie | None right now | None right now |
| Company | ||
| Founded | 2015 | 2015 |
| Team size | 201-500 employees | 51-200 employees |
| Headquarters | Toronto, Canada | London, UK |
| Featured clients | Pfizer, Novartis, Roche | Not available |